MannKind to Participate in the Chardan Healthcare Conference
Globe Newswire•14/10/2026•16:01 ET
5
Key Highlights
- ➤MannKind CEO Michael Castagna to join chronic respiratory disease innovation panel October 20
- ➤Management to hold one-on-one investor meetings at Chardan Healthcare Conference
- ➤Live webcast and approximately 90-day replay will be available online
Expert Statements
Michael Castagna, Chief Executive Officer of MannKind Corporation
“Michael Castagna will participate in a panel focused on innovation across chronic respiratory diseases at the Chardan Healthcare Conference.”
DANBURY, Conn. and WESTLAKE VILLAGE, Calif., Oct. 14, 2026 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), today announced that Chief Executive Officer Michael Castagna will participate in a panel focused on innovation across chronic respiratory diseases at the Chardan Healthcare Conference. Management will also participate in one-on-one meetings with investors during the conference.
Panel: Idiopathic Pulmonary Fibrosis & Chronic Respiratory Disease: Antifibrotics, CF, Bronchiectasis & COPD Innovation Date: Tuesday, October 20, 2026 Time: 2:00–2:30 p.m. ET
Get started
Create a free account to read the full story.